Go Pro

Context Therapeutics (CNTX) Institutional Ownership

Context Therapeutics logo
$0.35 -0.02 (-5.69%)
As of 02:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Context Therapeutics (NASDAQ:CNTX)

Current
Institutional Ownership
Percentage
14.03%
Number of
Institutional Buyers
(last 12 months)
24
Total
Institutional Inflows
(last 12 months)
$29.14M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$15.91M
Get CNTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Context Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CNTX Institutional Buying and Selling by Quarter

Context Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026 Squarepoint Ops LLC52,709$29K0.0%N/A0.057%
8/21/2026 Velan Capital Investment Management LP59,700$33K0.0%-40.3%0.065%
8/20/2026 Two Sigma Securities LLC61,444$34K0.0%+388.7%0.067%
8/17/2026 Bank of America Corp DE53,402$30K0.0%N/A0.058%
8/14/2026 ADAR1 Capital Management LLC750,969$416K0.0%N/A0.817%
8/13/2026 Clear Harbor Asset Management LLC92,804$51K0.0%N/A0.101%
8/11/2026 Blue Owl Capital Holdings LP2,934,015$1.63M0.2%N/A3.193%
8/8/2026 Timothy G. Youngquist 2020 Irrevocable Trust198,384$110K0.0%N/A0.216%
8/7/2026 BlackRock Inc.6,169,250$3.42M0.0%N/A6.714%
8/7/2026 Deutsche Bank AG90,882$50K0.0%N/A0.099%
8/6/2026 Bank of New York Mellon Corp109,362$61K0.0%N/A0.119%
8/6/2026 GSA Capital Partners LLP159,804$89K0.0%N/A0.174%
6/4/2026 Seven Fleet Capital Management LP190,785$500K0.2%N/A0.208%
5/28/2026 Avidity Partners Management LP4,998,267$13.10M2.6%-9.2%5.440%
5/19/2026 Bank of America Corp DE114,888$301K0.0%+12,213.8%0.125%
5/15/2026 Octagon Capital Advisors LP5,250,000$13.76M1.5%N/A5.714%
5/15/2026 OMERS ADMINISTRATION Corp80,600$211K0.0%N/A0.088%
5/14/2026 Renaissance Technologies LLC182,999$479K0.0%-64.0%0.199%
5/5/2026 Sanctuary Advisors LLC19,316$51K0.0%N/A0.021%
2/23/2026 Virtu Financial LLC28,921$43K0.0%N/A0.031%
2/18/2026 XTX Topco Ltd101,605$149K0.0%+858.8%0.111%
2/18/2026 Quadrature Capital Ltd46,220$68K0.0%N/A0.050%
2/18/2026 Millennium Management LLC2,601,216$3.82M0.0%N/A2.831%
2/17/2026 MPM Bioimpact LLC10,679,391$15.70M1.8%-27.4%11.623%
2/16/2026 Avidity Partners Management LP5,504,855$8.09M2.3%-38.7%5.991%
2/13/2026 Nantahala Capital Management LLC37,837$56K0.0%-97.7%0.041%
2/13/2026 Marshall Wace LLP2,593,198$3.81M0.0%+7,153.7%2.822%
2/13/2026 State Street Corp165,607$243K0.0%+8.5%0.180%
2/12/2026 Renaissance Technologies LLC508,329$747K0.0%+58.8%0.553%
2/9/2026 Blue Owl Capital Holdings LP7,432,906$10.93M0.8%+0.3%8.090%
11/17/2025 Qube Research & Technologies Ltd82,111$80K0.0%-23.1%0.089%
11/17/2025 Nantahala Capital Management LLC1,661,950$1.61M0.1%-14.1%1.809%
11/17/2025 Citadel Advisors LLC103,363$100K0.0%N/A0.112%
11/7/2025Vanguard Group Inc.3,495,031$3.39M0.0%+4.0%3.896%
10/23/2025 Clear Harbor Asset Management LLC92,804$90K0.0%+60.5%0.103%
8/14/2025 Qube Research & Technologies Ltd106,779$70K0.0%-38.7%0.119%
8/13/2025 Affinity Asset Advisors LLC518,025$339K0.0%-21.6%0.578%
8/13/2025 Walleye Capital LLC132,786$87K0.0%-21.4%0.148%
5/16/2025Ally Bridge Group NY LLC1,157,448$708K0.6%-26.6%1.290%
5/15/2025Landscape Capital Management L.L.C.41,216$25K0.0%-54.2%0.046%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
5/14/2025Affinity Asset Advisors LLC660,589$404K0.0%-34.9%0.736%
2/17/2025Velan Capital Investment Management LP90,000$94K0.1%-93.0%0.120%
2/17/2025Shay Capital LLC50,000$52K0.0%N/A0.067%
2/17/2025MPM Bioimpact LLC14,705,882$15.44M2.2%N/A19.608%
2/17/2025Millennium Management LLC178,718$188K0.0%+24.2%0.238%
2/17/2025Citadel Advisors LLC29,900$31K0.0%N/A0.040%
2/17/2025Allostery Investments LP950,166$998K1.0%N/A1.267%
2/17/2025Ally Bridge Group NY LLC1,576,762$1.66M1.4%-10.3%2.102%
2/14/2025Jane Street Group LLC27,395$29K0.0%N/A0.037%
2/14/2025Northern Trust Corp113,565$119K0.0%-34.2%0.151%
2/14/2025Blue Owl Capital Holdings LP6,357,928$6.68M1.6%+17.5%8.477%
2/13/2025Marshall Wace LLP203,286$213K0.0%N/A0.271%
2/13/2025Affinity Asset Advisors LLC1,015,340$1.07M0.1%-23.1%1.354%
2/13/2025Walleye Capital LLC166,306$175K0.0%+51.7%0.222%
2/13/2025Renaissance Technologies LLC338,435$355K0.0%+412.8%0.451%
2/13/2025ADAR1 Capital Management LLC351,094$369K0.1%-6.1%0.468%
2/12/2025Landscape Capital Management L.L.C.90,000$94K0.0%N/A0.120%
2/12/2025Geode Capital Management LLC628,729$661K0.0%+9.2%0.838%
2/12/2025Franklin Resources Inc.4,003,380$4.20M0.0%+115.9%5.338%
1/17/2025Clear Harbor Asset Management LLC57,804$61K0.0%+60.6%0.077%
11/27/2024Franklin Resources Inc.1,853,988$3.69M0.0%N/A2.472%
11/16/2024Geode Capital Management LLC575,899$1.13M0.0%-6.8%0.768%
11/15/2024Y Intercept Hong Kong Ltd45,635$89K0.0%N/A0.061%
11/15/2024State Street Corp111,907$219K0.0%+21.5%0.149%
11/14/2024Ally Bridge Group NY LLC1,757,524$3.45M1.8%-6.8%2.343%
11/13/2024Great Point Partners LLC6,934,982$13.59M4.0%-6.5%9.247%
8/20/2024Nantahala Capital Management LLC1,935,484$3.88M0.2%N/A2.581%
8/16/2024Driehaus Capital Management LLC2,258,065$4.53M0.0%N/A3.011%
8/15/2024Blue Owl Capital Holdings LP5,161,290$10.35M2.9%N/A6.882%
8/15/2024Affinity Asset Advisors LLC1,619,140$3.25M0.4%+392.4%2.159%
8/14/2024Great Point Partners LLC7,419,355$14.88M2.8%N/A9.893%
8/14/2024Ally Bridge Group NY LLC1,886,232$3.78M2.3%+159.8%2.515%
8/9/2024Renaissance Technologies LLC65,200$131K0.0%+63.4%0.087%
5/29/2024Opaleye Management Inc.1,108,357$1.53M0.3%+13.7%1.478%
2/15/2024Opaleye Management Inc.975,000$1.10M0.3%N/A6.107%
11/15/2023Affinity Asset Advisors LLC328,817$497K0.1%+22.9%2.059%
8/21/2023Affinity Asset Advisors LLC267,574$428K0.1%N/A1.675%
7/21/2023Clear Harbor Asset Management LLC36,000$58K0.0%N/A0.225%
2/16/2023AIGH Capital Management LLC1,143,745$745K0.2%-11.5%7.162%
2/14/2023swisspartners Ltd.180,000$119K0.2%+111.8%1.127%
11/14/2022Worth Venture Partners LLC322,628$358K0.2%+8.4%2.021%
11/1/2022swisspartners Ltd.85,000$94K0.1%+101.3%0.532%
8/13/2022Virtu Financial LLC46,445$98K0.0%N/A0.291%
8/12/2022Affinity Asset Advisors LLC883,654$1.87M0.8%+13.6%5.535%


CNTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 41 institutional investors and hedge funds held shares of Context Therapeutics. The most heavily invested institutionals were MPM Bioimpact LLC ($15.70M), Octagon Capital Advisors LP ($13.76M), Great Point Partners LLC ($13.59M), Avidity Partners Management LP ($13.10M), Franklin Resources Inc. ($4.20M), Millennium Management LLC ($3.82M), and Marshall Wace LLP ($3.81M).Learn more on Context Therapeutics' institutional investors.

14.03% of Context Therapeutics' stock is owned by institutional investors. Learn more on CNTX's institutional investor holdings.

Of the 33 institutional investors that purchased Context Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: MPM Bioimpact LLC ($14.71M), BlackRock Inc. ($6.17M), Octagon Capital Advisors LP ($5.25M), Franklin Resources Inc. ($4.00M), Blue Owl Capital Holdings LP ($3.91M), Marshall Wace LLP ($2.76M), and Millennium Management LLC ($2.64M).

Institutional investors have bought a total of 22,138,935 shares in the last 24 months. This purchase volume represents approximately $29.14M in transactions.

The following institutional investors have sold Context Therapeutics stock in the last 24 months: MPM Bioimpact LLC ($4.03M), Avidity Partners Management LP ($3.98M), Nantahala Capital Management LLC ($1.90M), Renaissance Technologies LLC ($325.33K), Velan Capital Investment Management LP ($40.30K), and Qube Research & Technologies Ltd ($24.67K).

Institutional investors have sold a total of 10,298,024 shares in the last 24 months. This volume of shares sold represents approximately $15.91M in transactions.



Institutional ownership data for NASDAQ:CNTX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners